Torrent Pharmaceuticals inches up on getting USFDA nod for generic hypertension drug

02 Dec 2011 Evaluate

Torrent Pharmaceuticals is currently trading at Rs 561.00, up by 5.15 points or 0.93% from its previous closing of Rs 555.85 on the BSE.

The scrip opened at Rs 560.00 and has touched a high and low of Rs. 562.00 and Rs 557.15 respectively. So far 343 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 5 has touched a 52 week high of Rs 686.95 on 21-Jul-2011 and a 52 week low of Rs 499.00 on 28-Apr-2011.

Last one week high and low of the scrip stood at Rs 579.00 and Rs 546.25 respectively. The current market cap of the company is Rs 4703.12 crore.

The promoters holding in the company stood at 71.51% while Institutions and Non-Institutions held 17.10% and 11.39% respectively.

Torrent Pharmaceuticals’ has received an approval of US Food and Drug Administration (USFDA) for its generic of AstraZeneca’s hypertension drug Plendil. The approval is for 2.5 mg, 5 mg and 10 mg strengths of Felodipine extended release tablets to be sold on prescription basis.

Felodipine is a calcium channel blocker (calcium antagonist), a drug used to control high blood pressure.

Torrent Pharma is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3792.65 -20.20 (-0.53%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×